Alector is a San Francisco-based biotechnology company that is dedicated to improving the lives of individuals affected by neurodegenerative diseases. With a focus on immuno-neurology, Alector aims to unlock new approaches and develop novel therapeutic candidates that harness the body's innate healing power.
Driven by boundless curiosity and a culture of courage, Alector is committed to asking bold questions and seeking answers to transform the inevitability of diseases of aging. Through their unmatched pipeline of potential medicines, Alector strives to make a profound impact on patients' lives by slowing or halting the decline associated with certain conditions.
Generated from the website